MedPath

Study to compare the effect of Abhaya Choorna and Abhaya Choorna with Vyayam in Obesity

Not yet recruiting
Conditions
Obesity, unspecified. Ayurveda Condition: STHAULYA,
Registration Number
CTRI/2021/02/030985
Lead Sponsor
Snehal Kedar
Brief Summary

The aim of the study is to see comparative effect of abhaya choorna and Abhaya choorna along with vyayama with anupana koshna jala in management of sthaulya patient.The study will be conducted with 60 patients showing sign and symptoms of sthaulya patient (16 years -40 years age )They will be adminstered with Abhaya choorna 3 gm in divided doses with koshna jala for 21 days and follow up done on 7,14 and 21st day and conclusion will be drawn on the basis of statistically methode.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria
  • 1.Patient having age 16-40 yrs.
  • 2.BMI above 30 were selected 3.Predominant kapha prakruti patients were selected 4.Uncomplicated sthaulya Patients were selected 5.Diagnosed patients of sthaulya 5.Patients willing to take treatment.
Exclusion Criteria
  • 1.Patients not willing for treatment 2.Any discomfort found during treatment 3.Obesity due to Certain secondary cause like pregnancy,drug induced 4.Sthaulya with jwara,prameha,pramehapeedaka etc.
  • 5.Who have undergone blood letting therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Abhaya choorna is effective in the management of sthaulya patient21 days study with 3 follow ups (7,14,21)
Secondary Outcome Measures
NameTimeMethod
Abhaya choorna along with Vyayam(Walking) is more effictive in sthaulya patients21 days study with 3 follow ups (7,14,21)

Trial Locations

Locations (1)

Dr D Y Patil College Of ayurveda Research Center

🇮🇳

Pune, MAHARASHTRA, India

Dr D Y Patil College Of ayurveda Research Center
🇮🇳Pune, MAHARASHTRA, India
Snehal Kedar
Principal investigator
8408044021
snehalkedar15@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.